The Safety and Efficiency of Tirofiban in Acute Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Multicenter Retrospective Cohort Study
Table 2
Operational details and operative period managements.
Characteristic
Tirofiban group N = 89
Control group N = 85
value
Pre rt-PA
27 (30.3)
22 (25.9)
0.514
OTP time, median (IQR), min
345 (244.0–419.5)
258.5 (194.0–322.7)
0.000
Local anesthesia
63 (70.8)
70 (82.4)
0.072
ASITN/SIR (1-2)
73 (82.0)
66 (77.6)
0.472
Number of passes, median (IQR)
2 (1–3)
2 (1–2)
0.738
Balloon angioplasty
27 (30.3)
6 (7.1)
0.000
Permanent stenting
21 (23.6)
7 (8.2)
0.006
mTICI ≥ 2b
68 (76.4)
48 (56.5)
0.005
Operative period antiplatelet
None
14 (15.7)
36 (42.4)
0.000
Aspirin/clopidogrel
22 (24.7)
27 (31.8)
Aspirin + clopidogrel
53 (59.6)
22 (25.9)
Postoperative treatment
Anticoagulation
17 (19.1)
38 (44.7)
0.000
Sedation
29 (32.6)
14 (16.5)
0.014
Dehydration
64 (71.9)
55 (64.7)
0.307
Data are number, number (%), median (IQR), or mean (SD). OTP time indicated time from onset to groin puncture.
